References
- Ren AN, Wang ZG, Lu ZC, Wang LW, Wu YL. 1999. Study on bacteriostasis and antivirotic of flowers Chrysanthemum indicum. Pharm Biotechnol 6: 241-244.
- Shunying Z, Yang Y, Huaidong Y, Yue Y, Guolin Z. 2005. Chemical composition and antimicrobial activity of the essential oils of Chrysanthemum indicum. J Ethnopharmacol 96: 151-158. https://doi.org/10.1016/j.jep.2004.08.031
- Aridoğan BC, Baydar H, Kaya S, Demirci M, Ozbaşar D, Mumcu E. 2002. Antimicrobial activity and chemical composition of some essential oils. Arch Pharm Res 25: 860-864. https://doi.org/10.1007/BF02977005
- Yoshikawa M, Morikawa T, Toguchida I, Harima S, Matsuda H. 2000. Medicinal flowers. II. Inhibitors of nitric oxide production and absolute stereostructures of five new germacrane-type sesquiterpenes, kikkanols D, D monoacetate, E, F, and F monoacetate from the flowers of Chrysanthemum indicum L.. Chem Pharm Bull 48: 651-656. https://doi.org/10.1248/cpb.48.651
- Kong LD, Cai Y, Huang WW, Cheng CH, Tan RX. 2000. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol 73: 199-207. https://doi.org/10.1016/S0378-8741(00)00305-6
- Cheng W, Li J, You T, Hu C. 2005. Anti-inflammatory and immunomodulatory activities of the extracts from the inflorescence of Chrysanthemum indicum Linne. J Ethnopharmacol 101: 334-337. https://doi.org/10.1016/j.jep.2005.04.035
- Yoshikawa M, Morikawa T, Murakami T, Toguchida I, Harima S, Matsuda H. 1999. Medicinal flowers. I. Aldose reductase inhibitors and three new eudesmane-type sesquiterpenes, kikkanols A, B, and C, from the flowers of Chrysanthemum indicum L.. Chem Pharm Bull 47: 340-345. https://doi.org/10.1248/cpb.47.340
- Matsuda H, Morikawa T, Toguchida I, Harima S, Yoshikawa M. 2002. Medicinal flowers. VI. Absolute stereostructures of two new flavanone glycosides and a phenylbutanoid glycoside from the flowers of Chrysanthemum indicum L.: their inhibitory activities for rat lens aldose reductase. Chem Pharm Bull 50: 972-975. https://doi.org/10.1248/cpb.50.972
- Jung BS, Shin MG. 1989. Hyangyak comprehensive dictionary. Younglimsa, Seoul, Korea. p 1038-1039.
- Ryu SY, Choi SU, Lee CO, Lee SH, Ahn JW, Zee OP. 1994. Antitumor activity of some phenolic components in plants. Arch Pharm Res 17: 42-44. https://doi.org/10.1007/BF02978247
- Uchio Y, Tomosue K, Nakayama M, Yamamura A, Waki T. 1981. Constituents of the essential oils from three tetraploid species of Chrysanthemum. Phytochem 20: 2691-2693. https://doi.org/10.1016/0031-9422(81)85269-7
- Mladenova K, Tsankova E, van Hung D. 1988. New sesquiterpenoids from Chrysanthemum indicum var. tuneful. Planta Med 54: 553-555. https://doi.org/10.1055/s-2006-962548
- Simoes CM, Schenkel EP, Bauer L, Langeloh A. 1988. Pharmacological investigations on Achyrocline satureioides (LAM.) DC., Compositae. J Ethnopharmacol 22: 281-293. https://doi.org/10.1016/0378-8741(88)90239-5
- Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. 1988. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314.
- Lee YH. 2002. Diagnosis and management of gout. J Korean Acad Fam Med 23: 261-266.
- Sutaria S, Katbamna R, Underwood M. 2006. Effectiveness of interventions for the treatment of acute and prevention of recurrent gout: a systematic review. Rheumatology 45: 1422-1431. https://doi.org/10.1093/rheumatology/kel071
- Health Insurance Review & Assessment Service. 2011. 2010 National Health Insurance Statistical Yearbook. Wonju, Korea. p 559-578.
- Lee YS, Kim KK, Kim NW. 2011. The physiological activities of bark extract of Albizia julibrissin. Korean J Food Preserv 18: 79-86. https://doi.org/10.11002/kjfp.2011.18.1.079
- Seo SJ, Kim NW. 2010. Physiological activities of leaf and root extracts from Liriope platyphylla. Korean J Food Preserv 17: 123-130.
- Jee SO. 2009. Antioxidant activities and whitening effect of the mulberry (Morus alba L.) root bark extracts. Korean J Plant Res 22: 145-151.
- Gilman AG, Goodman LS, Rall TW, Murad F. 1985. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. Macmillan, New York, NY, USA. p 712.
- Wortmann RL. 2005. Recent advances in the management of gout and hyperuricemia. Curr Opin Rheumatol 17: 319-324. https://doi.org/10.1097/01.bor.0000162060.25895.a5
- Jeong CY. 2002. The effect of phenobarbital on the dose-dependent pharmacokinetics of probenecid in rat. MS Thesis. Chonnam National University, Gwangju, Korea.
- Lee MH, Graham GG, Williams KM, Day RO. 2008. A benefit- risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?. Drug Saf 31: 643-665. https://doi.org/10.2165/00002018-200831080-00002
- Lee YS. 2007. Physiological activities of hot water extract from Ailanthus altissima. Korean J Food Preserv 14: 170-176.
- Kwak CS, Lee KJ, Chang JH, Park JH, Cho JH, Park JH, Kim KM, Lee MS. 2013. In vitro antioxidant, anti-allergic and anti-inflammatory effects of ethanol extracts from Korean sweet potato leaves and stalks. J Korean Soc Food Sci Nutr 42: 369-377. https://doi.org/10.3746/jkfn.2013.42.3.369
- Cho YJ. 2014. Biological activity of extracts from Chrysanthemum incidicum L. by ultrafine grinding. J Korean Soc Food Sci Nutr 43: 110-117. https://doi.org/10.3746/jkfn.2014.43.1.110
Cited by
- 기혈소통환(氣血疏通丸)이 Monosodium iodoacetate로 골관절염(骨關節炎)을 유도(誘導)한 랫드에 미치는 영향(影響) vol.33, pp.3, 2016, https://doi.org/10.6116/kjh.2018.33.3.45
- 제주 자생 감국 꽃 추출물 유래 flavonoid 화합물의 항산화 및 항염 활성 vol.36, pp.4, 2016, https://doi.org/10.12925/jkocs.2019.36.4.1259